MaxCyte (MXCT) Competitors $1.52 -0.10 (-6.17%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.52 -0.01 (-0.33%) As of 09/19/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT vs. NEXN, PHLT, PRTH, IBEX, THRY, RMR, NUTX, RPAY, ANPA, and SOHUShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Nexxen International (NEXN), Performant Healthcare (PHLT), Priority Technology (PRTH), IBEX (IBEX), Thryv (THRY), The RMR Group (RMR), Nutex Health (NUTX), Repay (RPAY), Rich Sparkle (ANPA), and Sohu.com (SOHU). These companies are all part of the "business services" industry. MaxCyte vs. Its Competitors Nexxen International Performant Healthcare Priority Technology IBEX Thryv The RMR Group Nutex Health Repay Rich Sparkle Sohu.com MaxCyte (NASDAQ:MXCT) and Nexxen International (NASDAQ:NEXN) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Do analysts recommend MXCT or NEXN? MaxCyte currently has a consensus target price of $7.00, suggesting a potential upside of 360.53%. Nexxen International has a consensus target price of $15.00, suggesting a potential upside of 58.06%. Given MaxCyte's higher probable upside, equities analysts plainly believe MaxCyte is more favorable than Nexxen International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Nexxen International 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, MXCT or NEXN? Nexxen International has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Nexxen International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte$38.63M4.19-$41.06M-$0.43-3.53Nexxen International$365.48M1.65$35.44M$0.6315.06 Does the media favor MXCT or NEXN? In the previous week, Nexxen International had 7 more articles in the media than MaxCyte. MarketBeat recorded 8 mentions for Nexxen International and 1 mentions for MaxCyte. MaxCyte's average media sentiment score of 1.76 beat Nexxen International's score of 0.42 indicating that MaxCyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MaxCyte 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Nexxen International 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in MXCT or NEXN? 68.8% of MaxCyte shares are owned by institutional investors. Comparatively, 54.2% of Nexxen International shares are owned by institutional investors. 3.3% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, MXCT or NEXN? MaxCyte has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Nexxen International has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Is MXCT or NEXN more profitable? Nexxen International has a net margin of 13.37% compared to MaxCyte's net margin of -125.22%. Nexxen International's return on equity of 13.64% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-125.22% -22.12% -19.10% Nexxen International 13.37%13.64%8.84% SummaryNexxen International beats MaxCyte on 11 of the 16 factors compared between the two stocks. Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$162.04M$3.14B$5.77B$10.45BDividend YieldN/A2.35%5.61%4.57%P/E Ratio-3.5320.9180.5026.82Price / Sales4.19262.05456.1891.69Price / CashN/A46.4637.6661.43Price / Book0.789.6015.756.39Net Income-$41.06M-$53.22M$3.30B$271.80M7 Day Performance4.83%3.11%5.35%3.51%1 Month Performance7.04%6.23%7.28%9.58%1 Year Performance-62.93%11.02%80.79%28.53% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte3.7364 of 5 stars$1.52-6.2%$7.00+360.5%-62.9%$162.04M$38.63M-3.5380Positive NewsNEXNNexxen International4.0278 of 5 stars$9.65-1.0%$15.00+55.4%+13.8%$618.32M$365.48M15.32895News CoverageGap UpPHLTPerformant Healthcare1.1343 of 5 stars$7.69+0.1%$7.88+2.4%N/A$617.78M$122.98M-769.00930News CoveragePositive NewsPRTHPriority Technology4.5504 of 5 stars$7.44-1.3%$13.00+74.7%+8.1%$602.58M$918.56M28.621,019Positive NewsShort Interest ↓IBEXIBEX1.7853 of 5 stars$38.85-6.6%$34.50-11.2%+105.1%$553.64M$558.27M16.2630,000Insider TradeHigh Trading VolumeTHRYThryv2.1968 of 5 stars$12.21-2.4%$21.40+75.3%-33.6%$549.64M$758.29M-5.153,016RMRThe RMR Group3.0505 of 5 stars$16.98-0.4%$24.00+41.3%-33.7%$543.38M$897.20M14.51600Positive NewsNUTXNutex Health2.2 of 5 stars$95.66-1.6%$252.50+164.0%+292.3%$539.90M$479.95M8.051,150Trending NewsUpcoming EarningsShort Interest ↑RPAYRepay3.5884 of 5 stars$5.66-3.9%$7.22+27.6%-37.1%$537.98M$310.37M-4.49580Positive NewsInsider TradeANPARich SparkleN/A$39.50-2.5%N/AN/A$506.38MN/A0.00N/ANews CoveragePositive NewsSOHUSohu.com3.4308 of 5 stars$15.54-2.6%$20.00+28.7%+3.9%$479.84M$598.40M3.734,300 Related Companies and Tools Related Companies Nexxen International Alternatives Performant Healthcare Alternatives Priority Technology Alternatives IBEX Alternatives Thryv Alternatives The RMR Group Alternatives Nutex Health Alternatives Repay Alternatives Rich Sparkle Alternatives Sohu.com Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MXCT) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXCT Stock Alerts